Rare diseases
Investigational molecules
Locations
101 Glen Lennox Drive Suite 300, 27517-4089, United States
Tenax Therapeutics Inc. focuses on pulmonary hypertension in the setting of heart failure with preserved left ventricular ejection fraction, addressing a cardiopulmonary condition marked by impaired exercise capacity and elevated pulmonary pressures.
The clinical program centers on improving functional status and evaluating treatment effects in patients with this overlapping cardiac and pulmonary vascular disorder.
Tenax Therapeutics Inc. runs clinical trials in conditions such as Pulmonary hypertension, among others.
Clinical trials run by this sponsor – those enrolling participants first.
AustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
